Craft

SANUWAVE Health

Stock Price

$19

2024-10-29

Market Capitalization

$22.4 B

2024-10-29

Revenue

$44.1 M

FY, 2025

SANUWAVE Health Summary

Company Summary

Overview
SANUWAVE Health is a company that specializes in treating diabetic foot ulcers. It develops and commercializes non-invasive devices for the repair and regeneration of bones, muscles, tendons, and skin. The company leverages the pulsed acoustic cellular expression (PACE) technology that uses high-energy acoustic pressure waves to help restore the body’s normal healing processes.
Type
Public
Status
Active
Founded
2005
HQ
Suwanee, GA, US | view all locations
Website
https://www.sanuwave.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Iulian Cioanta, Chief Science and Technology Officer

    • Peter Stegagno, Chief Operation Officer

      • Michael Stolarski, Director

        • Jack Schlechtweg, Chief Revenue Officer

          LocationsView all

          3 locations detected

          • Suwanee, GA HQ

            United States

            3360 Martin Farm Rd #100

          • Eden Prairie, MN

            United States

            11495 Valley View Rd

          • Madison, NJ

            United States

            170 Park Ave

          SANUWAVE Health Financials

          Summary Financials

          Revenue (Q1, 2026)
          $9.6M
          Gross profit (Q1, 2026)
          $7.4M
          Net income (Q1, 2026)
          ($1.4M)
          Cash (Q1, 2026)
          $10.8M
          EBIT (Q1, 2026)
          ($1.1M)
          Enterprise value
          $22.4B

          Footer menu